| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.39 | 0.2 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.2 |